Backs against the Wall: Novel and Existing Strategies Used during the 2014-2015 Ebola Virus Outbreak

Author:

Wong Gary12,Kobinger Gary P.1234

Affiliation:

1. Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada

2. Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada

3. Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada

4. Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Abstract

SUMMARY The 2014-2015 outbreak of Ebola virus (EBOV), originating from Guinea, is now responsible for the infection of >20,000 people in 9 countries. Whereas past filovirus outbreaks in sub-Saharan Africa have been rapidly brought under control with comparably few cases, this outbreak has been particularly resistant to containment efforts. Both the general population and primary health care workers have been affected by this outbreak, with hundreds of doctors and nurses being infected in the line of duty. In the absence of approved therapeutics, several caregivers have turned to investigational new drugs as well as experimental therapies in an effort to save lives. This review aims to summarize the candidates currently under consideration for postexposure use in infected patients during the largest EBOV outbreak in history.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,General Immunology and Microbiology,Epidemiology

Reference97 articles.

1. WHO. 11 March 2015. Ebola situation report—11 March 2015. WHO, Geneva, Switzerland. http://apps.who.int/ebola/current-situation/ebola-situation-report-11-march-2015 . Accessed 12 March 2015.

2. Estimating the future number of cases in the Ebola epidemic—Liberia and Sierra Leone, 2014-2015;Meltzer MI;MMWR Surveill Summ,2014

3. Infectious disease: Tough choices to reduce Ebola transmission

4. WHO. 20 October 2014. Nigeria is now free of Ebola virus transmission. WHO, Geneva, Switzerland. http://www.who.int/mediacentre/news/ebola/20-october-2014/en/index2.html . Accessed 15 January 2015.

5. WHO. 17 October 2014. The outbreak of Ebola virus disease in Senegal is over. WHO, Geneva, Switzerland. http://www.who.int/mediacentre/news/ebola/17-october-2014/en/ . Accessed 15 January 2015.

Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Activation of thousands of genes in the lungs and kidneys by sepsis is countered by the selective nuclear blockade;Frontiers in Immunology;2023-08-11

2. Passive Immunization;Principles and Practice of Pediatric Infectious Diseases;2023

3. Biodefence research two decades on: worth the investment?;The Lancet Infectious Diseases;2021-08

4. How To Prepare for the Unexpected: a Public Health Laboratory Response;Clinical Microbiology Reviews;2021-06-16

5. Ebola and Marburg Virus: A Brief Review;Emerging and Reemerging Viral Pathogens;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3